2m 2m 2m 2m 2m 2m 2m
CONTEXT THERAP (CNTX)
NASDAQ
$2.09-$0.33 (-13.84%)
Price as of Jun 03, 2026 7:55 PM EDT- $261.9MMarket Cap
- 315.81%1-Year Change
- BiotechnologyIndustry
CONTEXT THERAP (CNTX)
$2.09-$0.33 (-13.84%)
CNTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.42 | ||
Change | -$0.37 (-13.26%) | ||
Open | $2.77 | ||
High | $2.80 | ||
Low | $2.42 | ||
Previous Close | $2.79 | ||
Volume | 539,462 | ||
30-Day Average Volume | 644,888 | ||
1-Week Change | -7.98% | ||
1-Month Change | 6.61% | ||
1-Year Change | 315.81% | ||
3-Year Change | 89.06% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 91.9M | ||
Total Assets | $58.9M | ||
Market Cap | $261.9M | ||
Enterprise Value | $207.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$8.7M | ||
Free Cash Flow | -$11.5M | ||
EBIT | -$8.7M | ||
EBITDA | -$8.7M | ||
Net Working Capital | $52.0M | ||
EPS | -$0.09 | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -32 | ||
PEG | -1 | ||
Price/Free Cash Flow | -23 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue